David Hickey, EVP & President, Life Sciences at BECTON DICKINSON & CO (BDX), sold 7,805 shares at $277.85 ($2.2M) on 2023-08-11, disclosed to the SEC on 2023-08-14.
Scheduled sale ($2.2M) by EVP & President, Life Sciences under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $277.85 | 1,857 | $516K | 23.8% |
| 2 | $277.85 | 2,974 | $826K | 38.1% |
| 3 | $277.85 | 2,974 | $826K | 38.1% |
| Total | $277.85 avg | 7,805 | $2.2M | 100% |
| Filing → |
| BDX | SELL | 2021-09-08 | $130K | — | Filing → |